clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Carnegie Mellon Nets $80M+ For Cell-Based Bioelectronics to Monitor and Treat…
News & Features
Anti-Inflammatory Marker Holds Promise for Cardiovascular Vaccine
Molecular Dx
Veracyte’s RNA Genetic Test Predicts Black Men’s Aggressive Prostate Cancer
News & Features
New Drug Candidate Works to Inhibit Both Tau Protein “Hotspots” in…
News & Features
Early-Onset Colorectal Cancer Shows Sex-Specific Features
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Ergo Sum: Cartesian’s CAR-T Receives FDA Rare Pediatric Disease Designation
Phase III clinical trials (Drug development)
News & Features
Ergo Sum: Cartesian’s CAR-T Receives FDA Rare Pediatric Disease Designation
Jonathan D. Grinstein, PhD
September 19, 2024
0
News & Features
SOPHiA Presents Multimodal AI-Driven Research on Patient Stratification in Lung Cancer
September 18, 2024
0
News & Features
AstraZeneca’s Durvalumab Granted Priority Review for Form of Small Cell Lung Cancer
August 16, 2024
0
News & Features
Lilly’s Tirzepatide Improves Heart Failure Outcomes
August 1, 2024
0
News & Features
Diabetes, Obesity Drug Shows Efficacy Treating Obstructive Sleep Apnea in Phase III Trials
June 25, 2024
0
News & Features
Alnylam’s Vutrisiran Gets Good Results for Cardiac Amyloidosis
June 24, 2024
0
News & Features
Bayer’s Elinzanetant Shines in Phase III, Heating up Menopause Drug Market
May 20, 2024
0
Coronavirus
CureVac Announces Positive Phase II Data For mRNA Flu Vaccine
April 5, 2024
0
News & Features
Merck’s First-in-Class Drug for Pulmonary Arterial Hypertension Approved by the FDA
March 27, 2024
0
News & Features
Pericarditis Variants Signpost Personalize Treatments
December 27, 2023
0
1
2
3
...
7
Page 1 of 7
Related Content
Serious COVID-19 Cases Can Age the Brain Substantially for a Year or More
Novo Nordisk and NanoVation Inked $600M+ Genetic Medicine Deal
SOPHiA Presents Multimodal AI-Driven Research on Patient Stratification in Lung Cancer
Kisqali Nets FDA Expanded Approval in Early Breast Cancer
Inside Precision Medicine